Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koenigsmann, M.
Right arrow Articles by Cannistra, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenigsmann, M.
Right arrow Articles by Cannistra, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Myeloid and erythroid progenitor cells from normal bone marrow adhere to collagen type I

M Koenigsmann, JD Griffin, J DiCarlo and SA Cannistra

Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

One of the mechanisms by which normal hematopoietic progenitor cells remain localized within the bone marrow microenvironment is likely to involve adhesion of these cells to extracellular matrix (ECM) proteins. For example, there is evidence that uncommitted, HLA-DR-negative progenitor cells and committed erythroid precursors (BFU-E) bind to fibronectin. However, fibronectin is not known to mediate binding of committed myeloid (granulocyte-macrophage) progenitors, raising the possibility that other ECM proteins may be involved in this process. We investigated the binding of the MO7 myeloid cell line to a variety of ECM proteins and observed significant specific binding to collagen type I (56% +/- 5%), minimal binding to fibronectin (18% +/- 4%) or to laminin (19% +/- 5%), and no binding to collagen type III, IV, or V. Similarly, normal bone marrow myeloid progenitor cells (CFU-GM) demonstrated significant specific binding to collagen type I (46% +/- 8% and 47% +/- 12% for day 7 CFU-GM and day 14 CFU-GM, respectively). The ability of collagen to mediate binding of progenitor cells was not restricted to the myeloid lineage, as BFU-E also showed significant binding to this ECM protein (40% +/- 10%). The binding of MO7 cells and CFU-GM was collagen-mediated, as demonstrated by complete inhibition of adherence after treatment with collagenase type VII, which was shown to specifically degrade collagen. Binding was not affected by anti-CD29 neutralizing antibody (anti-beta-1 integrin), the RGD-containing peptide sequence GRGDTP, or divalent cation chelation, suggesting that collagen binding is not mediated by the beta-1 integrin class of adhesion proteins. Finally, mature peripheral blood neutrophils and monocytes were also found to bind to collagen type I (25% +/- 8% and 29% +/- 6%, respectively). These data suggest that collagen type I may play a role in the localization of committed myeloid and erythroid progenitors within the bone marrow microenvironment.

Volume 79, Issue 3, pp. 657-665, 02/01/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y.-Y. Jang and S. J. Sharkis
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
Blood, October 15, 2007; 110(8): 3056 - 3063.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N. Askenasy, T. Zorina, D. L. Farkas, and I. Shalit
Transplanted Hematopoietic Cells Seed in Clusters in Recipient Bone Marrow In Vivo
Stem Cells, July 1, 2002; 20(4): 301 - 310.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Siler, M. Seiffert, S. Puch, A. Richards, B. Torok-Storb, C. A. Muller, L. Sorokin, and G. Klein
Characterization and functional analysis of laminin isoforms in human bone marrow
Blood, December 15, 2000; 96(13): 4194 - 4203.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. M. Pruijt, W. E. Fibbe, L. Laterveer, R. A. Pieters, I. J. D. Lindley, L. Paemen, S. Masure, R. Willemze, and G. Opdenakker
Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the Metalloproteinase gelatinase B (MMP-9)
PNAS, September 14, 1999; 96(19): 10863 - 10868.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Quesenberry and P. S. Becker
Stem cell homing: Rolling, crawling, and nesting
PNAS, December 22, 1998; 95(26): 15155 - 15157.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. K. Nilsson, M. E. Debatis, M. S. Dooner, J. A. Madri, P. J. Quesenberry, and P. S. Becker
Immunofluorescence Characterization of Key Extracellular Matrix Proteins in Murine Bone Marrow In Situ
J. Histochem. Cytochem., March 1, 1998; 46(3): 371 - 378.
[Abstract] [Full Text]


Home page
Stem CellsHome page
K. Sugiura, M. Inaba, H. Hisha, K. Borisov, E. E. Sardiña, R. A. Good, and S. Ikehara
Requirement of Major Histocompatibility Complex-Compatible Microenvironment for Spleen Colony Formation (CFU-S on day 12 but not on day 8)
Stem Cells, November 1, 1997; 15(6): 461 - 468.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
E Barbe, I Huitinga, E. Dopp, J Bauer, and C. Dijkstra
A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding
J. Cell Sci., January 12, 1996; 109(12): 2937 - 2945.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020